Learning Objectives:

 
By the end of this session, participants will be able to:
 

1) Explain a PK-PD relationship

2) Describe the pharmacokinetics and pharmacodynamics of hydroxychloroquine
3) Evaluate recent literature regarding the PK-PD relationship of hydroxychloroquine in lupus
4) Critically appraise a clinical pharmacology study for hydroxycloroquine in pediatric lupus patients at Duke

Location: 
Duke South 3rd Floor Conference Room (purple zone)
200 Trent Drive
Durham, NC 27710
United States
See map: Google Maps
Session date: 
04/26/2016 - 8:00am to 9:00am EDT

Please login or register to take this course.
Room Number: 
3031
Speaker Name: 
Stephen Balevic, MD